Related Experiment Video
Updated: Apr 5, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
Amyotrophic lateral sclerosis: Current perspectives from basic research to the clinic.
Renzo Mancuso1, Xavier Navarro1
1Institute of Neurosciences and Department of Cell Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Bellaterra, Spain.
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease. This review summarizes research on ALS evaluation, models, pathophysiology, and clinical findings to advance therapeutic strategies.
Area of Science:
- Neuroscience
- Neurology
- Genetics
Background:
- Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by motor neuron loss.
- Recent research advances offer new insights into ALS pathophysiology and potential therapeutic targets.
Purpose of the Study:
- To review current knowledge on ALS, encompassing evaluation methods, animal models, pathophysiology, and clinical findings.
- To elucidate the mechanisms underlying motor neuron degeneration in ALS.
- To identify promising avenues for developing novel therapeutic strategies.
Main Methods:
- Comprehensive literature review of recent findings in ALS research.
- Analysis of data from experimental models and clinical studies.
- Synthesis of information on disease mechanisms and therapeutic approaches.
Main Results:
- Significant progress has been made in understanding ALS at basic and preclinical levels.
- Various contributing mechanisms to motor neuron degeneration have been identified.
- Experimental models and clinical findings provide a foundation for translational research.
Conclusions:
- A deeper understanding of ALS pathophysiology is crucial for developing effective treatments.
- Continued research integrating basic science, preclinical models, and clinical findings is essential.
- This review highlights key areas for future research and therapeutic development in ALS.
Related Concept Videos
Parkinson's Disease: Overview
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Satellite Stem Cells and Muscular Dystrophy
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Alzheimer's Disease: Treatment

